arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

NeuroPace Inc

NPCE

$14.79 ▲ +0.88 (+6.33%) at close

7 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

NeuroPace Inc faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $484.0M

Dividend Yield —

Revenue Growth 25.1% ↗

Op. Margin -16.3% ↗

ROIC -16.6% ↗

FCF / Share $-0.35 ↗

Trailing P/E —

Price / Book 26.1x

FCF Yield —

Debt / Equity 3.09

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$99.99M

↑ +25.1% —

Net Income Profit after all expenses

$-21.46M

↑ +20.9% —

Operating Margin Operating profit as % of sales

-16.3%

↑ +39.7% 11th

FCF / Share Free cash flow per share

$-0.35

↑ +44.7% —

Long-Term Debt Long-term obligations

$58.88M

↓ -1.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality ↓

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2019

FY 2020

FY 2021

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	25.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+214%)	22.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+177%)	43.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+446%)	0.7% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-91%)	9.8% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+23%)	—	—
EPS Growth YoY (%)	29.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	26.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	33.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	12.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	98.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	20.9% Good ↑ Good Improving Year-over-year change in net income	17.6% Good ↑ Good Improving Year-over-year change in net income	30.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.5% Weak Weak Year-over-year change in net income	-48.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	44.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	18.5% Good ↓ Good Declining Year-over-year change in free cash flow	49.5% Excellent → Excellent Stable Year-over-year change in free cash flow	-1.4% Weak Weak Year-over-year change in free cash flow	98.6% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	30.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	20.9% Excellent Excellent Compound annual revenue growth over 3 years	16.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-16.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-209%)	-27.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-281%)	-41.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-377%)	-89.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-697%)	-52.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-450%)	-31.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-311%)	—
Profit Margin (%) (%)	-21.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-279%)	-34.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-383%)	-50.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-520%)	-103.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-962%)	-79.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-765%)	-59.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-592%)	—
FCF Margin (%) (%)	-11.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-22.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-30.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-82.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-55.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-52.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-16.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-27.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	10.6% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-15.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-35.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-112.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-852%)	—	-159.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1164%)	-135.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1003%)	-49.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	16.4% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	3.09x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+416%)	7.43x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1138%)	2.76x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+360%)	1.52x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+154%)	0.68x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+13%)	-0.34x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-157%)	—
Interest Coverage (x)	-2.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$37.19M	$46.09M	$38.90M	$46.31M	$30.66M	$24.43M	—
Debt / EBITDA (x)	-3.66x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.77x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.31x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.99x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$3.06	$2.74	$2.53	$1.85	$2.72	$201.59	—
Basic EPS, GAAP (USD)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	$-117.85	—
Free Cash Flow per Share (USD)	$-0.35	$-0.63	$-0.77	$-1.52	$-1.50	$-106.19	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	—	—	—	—
Book Value per Share (USD)	$0.57	$0.27	$0.74	$1.39	$3.01	$-470.66	—
Tangible Book Value per Share (USD)	$0.57	$0.27	$0.74	$1.39	$3.01	$-470.66	—
Basic Weighted Avg Shares (shares)	32.72M	29.13M	25.85M	24.59M	16.61M	204,068	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$76.26M	$66.18M	$76.49M	$86.74M	$123.52M	$44.97M	—
LT Debt (USD)	$58.88M	$59.52M	$56.95M	$52.91M	$49.85M	$50.82M	—
Total Equity (USD)	$19.03M	$8.01M	$20.65M	$34.78M	$73.50M	$-147.83M	$-129.35M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$99.99M	$79.91M	$65.42M	$45.52M	$45.18M	$41.14M	—
Depreciation Expense (USD)	$238.00K	$207.00K	$172.00K	$267.00K	$296.00K	$312.00K	—
Net Income, GAAP (USD)	$-21.46M	$-27.14M	$-32.96M	$-47.08M	$-36.08M	$-24.28M	—
Operating Cash Flow (USD)	$-11.01M	$-17.95M	$-19.70M	$-36.87M	$-24.58M	$-21.61M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

NeuroPace Inc

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NPCE with peers